Tag:
Edurant
Latest Headlines
Latest Headlines
FDA green lights combo HIV drug from J&J, Gilead
Collaborators at Johnson & Johnson and Gilead have won FDA approval of a new combo treatment for HIV expected to earn more than a half billion dollars a year. The agency announced yesterday
UPDATED: J&J is on a roll as drug deals deliver blockbuster approvals
J&J never has won much praise for its science. The pharma giant, though, can spot a promising treatment in the pipeline, which it proved two years ago when it paid a billion dollars to buy up
